UPDATE: Oppenheimer Lowers PT to $57 on DeVry

Loading...
Loading...
A report from Oppenheimer reiterates it Outperform rating and lowers it price target from $70 to $57 on DeVry
DV
. The report states, “September total enrollment decreased 0.9% y/y. Despite DeVry Undergrad & Carrington concerns, positive growth in enrollment occurred at all currently reporting segments, with DeVry Graduate total enrollment +2% y/y, DeVry Medical (Ross/AUC aggregate) new/total enrollments +23%+6% y/y, and DeVry Brasil new/total enrollments +29%/+18% y/y. We anticipate Chamberlain growth to remain solid." DV closed yesterday at $46.08.
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: Analyst ColorEarningsNewsPrice TargetAnalyst RatingsOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...